Kinlin School's case-based experiential learning approach
Cases are stories about real people facing real problems in real businesses. Exploring these cases gives students a unique opportunity to take on the role of a decision-maker and simulate the very challenges that real managers and leaders face. The depth and intensity of the experience encourages students to encounter other points of view, examine their biases and clarify their values. In the end, learning becomes personal, enduring and profound.
Teaching business concepts using cases has a long tradition. The Lawrence Kinlin School of Business is proud to offer a refined case method that aligns with and delivers on the promise of experiential learning that is a key feature of the Kinlin School's learning experience. Students not only learn specific tools to analyze problems, they also learn about their own thinking styles and habits, as well as learn to reassess their ideas when situations change.
Students are taught to analyze a case using a standardized pattern with respected analytical tools. This Kinlin School tool box arms students to be effective problem-solvers even before they graduate, creating the kind of employees that businesses prefer.
Introducing Kinlin School's case study repository: In Perspective
To fuel this approach to teaching, the Kinlin School has created a case study repository: In Perspective. The Kinlin School publishes new, relevant cases specifically designed for college and applied undergraduate students. The cases are short (two to eight pages), to-the-point and are always about real situations with real people presented in a writing style that is clear and easy-to-read. These cases are collected in the case repository, which is searchable by keyword, business sector, business discipline and author.
For more information or assitance regarding the In Perspective Kinlin Case Repository:
- The Fanshawe College 2020 United Way campaign kicked off October 8, 2020 and will run until the end of January 2021.
- Fanshawe College’s Centre for Research and Innovation has developed a safe, rapid and inexpensive method to identify the effectiveness of potential COVID-19 drug treatments.